Pendal Group LTD Pacira Bio Sciences, Inc. Transaction History

Pendal Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$36.31 - $46.83 $819,698 - $1.06 Million	-22,575 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$35.66 - $44.99 $64,152 - $80,937	-1,799 Reduced 7.38%	22,575 $859,000
Q2 2019 Aug 01, 2019	BUY	$36.57 - $47.97 $46,517 - $61,017	1,272 Added 5.51%	24,374 $0
Q4 2018 Jan 30, 2019	SELL	$41.31 - $52.16 $9,253 - $11,683	-224 Reduced 0.96%	23,102 $993,000
Q2 2018 Jul 18, 2018	BUY	$27.5 - $39.8 $54,312 - $78,605	1,975 Added 9.25%	23,326 $0
Q1 2018 May 08, 2018	BUY	$29.98 - $46.35 $8,574 - $13,256	286 Added 1.36%	21,351 $0
Q4 2017 Feb 06, 2018	BUY	$31.85 - $46.95 $11,497 - $16,948	361 Added 1.74%	21,065 $0
Q3 2017 Nov 01, 2017	BUY	$35.7 - $39.5 $292,597 - $323,742	8,196 Added 65.53%	20,704 $0
Q2 2017 Aug 11, 2017	BUY	N/A	12,508	12,508 $0

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.